BrightBid Group AB (publ)
Research BrightBid Group AB (publ) (PERP-B) on Bullrun: market cap SEK 19.85M, P/E 8.3. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPERP-B
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Market capSEK 19.85M
- P/E8.3
- Financial periodQ1 2026
- RevenueSEK 4.98M
- Net income-SEK 2.07M
- Free cash flow-SEK 3.23M
- Gross margin52.8%
Valuation Snapshot
latest market cap is SEK 19.85M; P/E is 8.3.
Peer valuation comparison
Latest P/E is 8.29x versus a Healthcare sector median of 24.61x (66.3% below).
Latest P/E is 8.29x versus a Sweden median of 18.18x (54.4% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 14.56M | SEK 2.45M | -SEK 7.48M | 52.2% | 0.56 | SEK 4.33M | SEK 178.25K | SEK 19.76M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-03 | SEK 19.85M | 8.3 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About BrightBid Group AB (publ)
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. It provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is BrightBid Group AB (publ)'s market cap?
BrightBid Group AB (publ)'s market capitalization is SEK 19.85M.
What is BrightBid Group AB (publ)'s P/E ratio?
BrightBid Group AB (publ)'s price-to-earnings (P/E) ratio is 8.3.
What does BrightBid Group AB (publ) do?
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. It provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024.